# Safety and Efficacy Study of Dysport RU and Glabellar Lines

> **NCT01333397** · PHASE2 · COMPLETED · sponsor: **Ipsen** · enrollment: 176 (actual)

## Conditions studied

- Glabellar Frown Lines

## Interventions

- **BIOLOGICAL:** Botulinum toxin type A
- **BIOLOGICAL:** Botulinum toxin type A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01333397
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 176 (ACTUAL)
- **Last updated:** 2022-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01333397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01333397, "Safety and Efficacy Study of Dysport RU and Glabellar Lines". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01333397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*